What is Vincristine-doxorubicin-dexamethasone (VAD)?

Category: Prescription Drugs

false

See also: Doxorubicin Vincristine

Vincristine-doxorubicin-dexamethasone, also known as VAD, is a regimen that may be used for the treatment of multiple myeloma. It contains the anticancer agents vincristine and doxorubicin along with dexamethasone, a corticosteroid.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
0
Moderate
0
Mild
1
None
0

Commonly reported side effects and conditions associated with Vincristine-doxorubicin-dexamethasone (VAD)

Side effect Patients

Why patients stopped taking Vincristine-doxorubicin-dexamethasone (VAD)

Multiple reasons could be selected

Reason Patients
Doctor's advice 2
Course of treatment ended 1
Other 1
Side effects too severe 1
See all 3 patients who've stopped taking Vincristine-doxorubicin-dexamethasone (VAD)

Duration

Stopped taking Vincristine-doxorubicin-dexamethasone (VAD)

Duration Patients
Less than 1 month 1
1 - 6 months 1
2 - 5 years 1
Adherence
Adherence Evaluations
Always 0
Usually 1
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 1
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 1
Not specified 0
Last updated:

1 patient evaluation for Vincristine-doxorubicin-dexamethasone (VAD)

Feb 1, 2010 (Started Jan 07, 2007)

  • Effectiveness
    Can't tell (for Other)
  • Side effects
    Mild
  • Adherence
    Usually
  • Burden
    Not at all hard to take
Dosage: Daily
Cost: < $25 monthly

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Vincristine-doxorubicin-dexamethasone (VAD)